On SABCS 2024's final day, Dr. Jean-Pierre Ayoub discusses three key abstracts, including NSABP B-59/GBG-96-GeparDouze on immunotherapy in TNBC and a subgroup analysis of TAILORx exploring chemotherapy variations. Valuable insights shared!
5:28
0